CD8A and neoplasm: In contrast, in mice with PANC-1 and MIAPaCa-2 pancreatic cancer xenografts, daily administration of antagonist SB290157 resulted in a significant tumour growth delay which was mediated by infiltration of natural killer cells and was independent from CD8+ T cells [53].